Evidence map›Paper›PMID 35135911›Full record

ArticleInternal medicine (Tokyo, Japan)2022

Obstructive Pneumonia Associated with Endobronchial Aspergilloma: Successful Treatment with Interventional Bronchoscopy and Antifungals.

Masamichi Komatsu, Masanori Yasuo, Yosuke Wada, Munetake Takata, Hisanori Azuhata, Yuichi Ikuyama, Jumpei Akahane, Kei Sonehara, Atsuhito Ushiki, Hiroshi Yamamoto and 1 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Aspergilloma Presenting as Endobronchial Mass.Tuberculosis and respiratory diseases · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Masamichi KomatsuFirst Department of Internal Medicine, Shinshu University School of Medicine, Japan.
Masanori YasuoDepartment of Clinical Laboratory Sciences, Shinshu University School of Health Sciences, Japan.
Yosuke WadaFirst Department of Internal Medicine, Shinshu University School of Medicine, Japan.
Munetake TakataDepartment of Respiratory Medicine, Aizawa Hospital, Japan.
Hisanori AzuhataDepartment of Diagnostic Pathology, Aizawa Hospital, Japan.
Yuichi IkuyamaFirst Department of Internal Medicine, Shinshu University School of Medicine, Japan.
Jumpei AkahaneFirst Department of Internal Medicine, Shinshu University School of Medicine, Japan.
Kei SoneharaFirst Department of Internal Medicine, Shinshu University School of Medicine, Japan.
Atsuhito UshikiFirst Department of Internal Medicine, Shinshu University School of Medicine, Japan.
Hiroshi YamamotoFirst Department of Internal Medicine, Shinshu University School of Medicine, Japan.
Masayuki HanaokaFirst Department of Internal Medicine, Shinshu University School of Medicine, Japan.
Shinshu University · JPAizawa Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endobronchial aspergilloma is a rare disease. A 64-year-old man with severe diabetes mellitus developed a cough and fever and was referred to our hospital. He was diagnosed with obstructive pneumonia associated with endobronchial aspergilloma, underwent interventional bronchoscopy, and was treated with antifungals. While the optimal treatment has not been established, interventional bronchoscopy along with systemic antifungals may improve the outcome in such cases.

Indexed as

PneumoniaPulmonary AspergillosisAntifungal AgentsBronchoscopyHumansMaleMiddle AgedAntifungal Agentsaspergillusendobronchial aspergillomainterventional bronchoscopy

Identifiers

PMID35135911
PMCPMC9492488
OpenAlexW4210842672

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.